当前位置: X-MOL 学术Cytom. Part B Clin. Cytom. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition
Cytometry Part B: Clinical Cytometry ( IF 3.4 ) Pub Date : 2020-08-01 , DOI: 10.1002/cyto.b.21938
Devasis Panda 1 , Gaurav Chatterjee 1 , Twinkle Khanka 1 , Sitaram Ghogale 1 , Yajamanam Badrinath 1 , Nilesh Deshpande 1 , Rohan Sardana 1 , Anumeha Chaturvedi 1 , Sweta Rajpal 1 , Dhanalaxmi Shetty 2 , Nikhil V Patkar 1 , Sumeet Gujral 1, 3 , Papagudi G Subramanian 1 , Prashant R Tembhare 1
Affiliation  

Myeloid neoplasm with blasts showing mast cell (MC)-differentiation and MC-component less than 10% of all nucleated cells but not fulfilling the criteria for systemic mastocytosis with associated hematological neoplasm (SM-AHN) or myelomastocytic leukemia (MML) has not been described in the literature. Herein, we report a study of diverse myeloid malignancies with blasts showing MC-differentiation but not meeting the criteria for SM-AHN or MML. We also evaluated the utility of flow-cytometric immunophenotyping (FCI) in the characterization of immature-MCs (iMCs).

中文翻译:

多种骨髓肿瘤中白血病母细胞的肥大细胞分化:一种潜在的前骨髓肥大细胞白血病病症

原始细胞显示肥大细胞 (MC) 分化且 MC 成分少于所有有核细胞的 10%,但不符合系统性肥大细胞增多症伴相关血液肿瘤 (SM-AHN) 或骨髓肥大细胞白血病 (MML) 的标准的骨髓肿瘤尚未得到证实文献中描述。在此,我们报告了一项针对多种骨髓恶性肿瘤的研究,其中原始细胞显示 MC 分化,但不符合 SM-AHN 或 MML 标准。我们还评估了流式细胞免疫表型分析 (FCI) 在未成熟 MC (iMC) 表征中的效用。
更新日期:2020-08-01
down
wechat
bug